MedCity News May 9, 2021
Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a type of heart disease. It’s part of a broader push by Mayo Clinic to commercialize AI-based diagnostic tools, starting with spinout company Anumana.
After spinning up a pair of companies to commercialize remote diagnostic tools, Mayo Clinic shared the results of a study indicating an AI algorithm could be used to improve diagnosis of a certain type of heart disease.
The algorithm, which was developed internally at Mayo Clinic using a type of neural network, was designed to screen for low ejection fraction, a condition where the heart can’t contract strongly enough to...